ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 717,80
1,26%
DAX
18 518,03
-0,44%
Brent Oil
83,385
-1,13%
Bitcoin
64 970,99
0,18%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
28/04/202022h30GlobeNewswire Inc.Intellia Therapeutics to Present New Preclinical Data from Its CRISPR/Cas9 Programs at the 23rd Annual Meeting of the Ame...NASDAQ:NTLAIntellia Therapeutics Inc
24/04/202022h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NTLAIntellia Therapeutics Inc
24/04/202022h04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
09/04/202023h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
31/03/202013h30GlobeNewswire Inc.FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Un...NASDAQ:NTLAIntellia Therapeutics Inc
30/03/202020h55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTLAIntellia Therapeutics Inc
04/03/202023h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/202023h33Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/202022h49Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/202013h30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
20/02/202013h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
14/02/202017h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
10/02/202013h30GlobeNewswire Inc.Intellia Therapeutics Presents New Data From Its Engineered Cell Therapy and In Vivo Programs at Keystone Symposia’s Engine...NASDAQ:NTLAIntellia Therapeutics Inc
09/01/202013h30GlobeNewswire Inc.Intellia Therapeutics Highlights Recent Progress and Anticipated 2020 MilestonesNASDAQ:NTLAIntellia Therapeutics Inc
26/11/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at Evercore ISI 2nd Annual HealthCONx ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201922h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
31/10/201912h30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2019 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
24/10/201914h00GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
24/10/201913h30GlobeNewswire Inc.Intellia Therapeutics Presents In Vivo and Ex Vivo Data at the 2019 Annual Congress of the European Society of Gene and Cell ...NASDAQ:NTLAIntellia Therapeutics Inc
16/10/201914h00GlobeNewswire Inc.Intellia Therapeutics Announces Presentations at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (E...NASDAQ:NTLAIntellia Therapeutics Inc
30/09/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at October Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
26/09/201922h30GlobeNewswire Inc.Arbitration Decision Affirms Intellia Therapeutics’ Interpretation of Licensing Agreement with Caribou Biosciences on the C...NASDAQ:NTLAIntellia Therapeutics Inc
13/09/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTLAIntellia Therapeutics Inc
30/08/201923h14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NTLAIntellia Therapeutics Inc
23/08/201923h20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NTLAIntellia Therapeutics Inc
01/08/201913h30GlobeNewswire Inc. Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
30/07/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at August Healthcare Investor ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
25/07/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
09/07/201914h54Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTLAIntellia Therapeutics Inc
30/05/201922h30GlobeNewswire Inc.Intellia Therapeutics to Participate at June Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

NASDAQ
CSCD
LSE
IBGM
Ishr E Gov 7-10
NASDAQ
EVLV
Evolv Technologies
NYSE
CUBI-E
Customers Bancorp
BIT
F18093
Vontobel Financial Produ...
BIT
GOAI
Amundi Stoxx Gbl Artific...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés